pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
durvalumab + IPH-5201
Non-Small Cell Lung Cancer
$AZN
ASTRAZENECA PLC
Phase 2
dutogliptin tartrate
dutogliptin tartrate
Post-Myocardial Infarction
Recardio Inc
Phase 2
duvalgagene otiparvovec
duvalgagene otiparvovec
Fabry Disease
$FDMT
4D Molecular Therapeutics, Inc.
← prev
page 37 of 53
next →
131
Pain
89
Neurology
1
Phase 2
efarindodekin alfa
efarindodekin alfa[INN]
Cervical Cancer
$GILD
GILEAD SCIENCES, INC.
Phase 2
efdoralprin alfa
efdoralprin alfa [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$SNY
Sanofi
Phase 2
efgitasialase alfa
efgitasialase alfa
Breast Cancer
Palleon Pharmaceuticals Inc
Phase 2
efineptakin alfa
efineptakin alfa
Radiation Toxicity (Radiation Sickness, Acute Radiation S…
NeoImmuneTech Inc
Phase 2
efinopegdutide
efinopegdutide
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
$MRK
Merck & Co., Inc.
Phase 2
efocipegtrutide
efocipegtrutide [INN]
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Hanmi Pharmaceuticals Co Ltd
Phase 2
efpegerglucagon
efpegerglucagon [INN]
Hyperinsulinemia
Hanmi Pharmaceuticals Co Ltd
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Dise…
$ATYR
aTYR PHARMA INC
Phase 2
egalognastat
egalognastat [INN]
Progressive Supranuclear Palsy
Grupo Ferrer Internacional SA
Phase 2
elecoglipron
elecoglipron
Type 2 Diabetes
$AZN
ASTRAZENECA PLC
Phase 2
elezanumab
elezanumab
Traumatic Spinal Cord Injury
$ABBV
AbbVie Inc.
Phase 2
elifactant
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
Phase 2
elironrasib
elironrasib
Non-Small Cell Lung Cancer
$RVMD
Revolution Medicines, Inc.
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
Phase 2
elraglusib
elraglusib
Neuroblastoma
$ACTU
ACTUATE THERAPEUTICS, INC.
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
Phase 2
elunetirom
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
Phase 2
elzovantinib
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
Phase 2
emicizumab
Hemlibra (emicizumab-kxwh)
Acquired Hemophilia A
Chugai Pharmaceutical Co Ltd
Phase 2
emodepside
emodepside
Onchocerciasis (River Blindness)
Bayer AG
Phase 2
emraclidine
emraclidine
Psychosis
$ABBV
AbbVie Inc.
Phase 2
emrusolmin
emrusolmin [INN]
Multiple System Atrophy (Multi-System Degeneration)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Phase 2
emugrobart
emugrobart [INN]
Obesity
F. Hoffmann-La Roche Ltd
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
Phase 2
encoberminogene rezmadenovec
encoberminogene rezmadenovec
Refractory Angina
XyloCor Therapeutics Inc
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$ATOS
ATOSSA THERAPEUTICS, INC.
Phase 2
enekinragene inzadenovec
enekinragene inzadenovec
Osteoarthritis
$PCRX
Pacira BioSciences, Inc.
